Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LQR House | YHC | Dec 24, 2024 | 1.05 | 0.00 |
LQR House | LQR | Dec 24, 2024 | 1.15 | 0.00 |
LSB Industries | LXU | Dec 24, 2024 | 7.72 | +0.78 |
LSI Industries | LYTS | Dec 24, 2024 | 19.55 | +3.28 |
Ltc Properties | LTC | Dec 24, 2024 | 34.73 | +0.70 |
Lucas GC | LGCL | Dec 24, 2024 | 0.53 | -1.16 |
Lucid Diagnostics | LUCD | Dec 24, 2024 | 0.76 | -1.39 |
Lucid Group | LCID | Dec 24, 2024 | 3.20 | +3.23 |
Lucky Strike Entertainment A | LUCK | Dec 24, 2024 | 10.57 | 0.00 |
Lufax ADR | LU | Dec 24, 2024 | 2.39 | -1.65 |
Lululemon Athletica | LULU | Dec 24, 2024 | 385.69 | +0.57 |
Lulus Fashion Lounge | LVLU | Dec 24, 2024 | 1.16 | +7.41 |
Lumen Technologies | LUMN | Dec 24, 2024 | 5.82 | -0.34 |
Lument Finance Trust | LFT | Dec 24, 2024 | 2.74 | -0.36 |
Lument Finance Trust A Pref | LFT-A | Dec 24, 2024 | 23.30 | 0.00 |
Lumentum | LITE | Dec 24, 2024 | 84.34 | +1.35 |
Luminar Technologies A | LAZR | Dec 24, 2024 | 5.18 | +2.78 |
Lumos Pharma | LUMO | Dec 24, 2024 | 4.34 | 0.00 |
Luna Innovations | LUNA | Dec 24, 2024 | 1.62 | +3.18 |
Luokung Technology | LKCO | Dec 24, 2024 | 1.71 | +7.04 |
Luxfer | LXFR | Dec 24, 2024 | 13.25 | +1.15 |
LuxUrban Hotels | LUXH | Dec 24, 2024 | 0.96 | -2.24 |
Luxurban Hotels Pref | LUXHP | Dec 24, 2024 | 15.30 | +2.00 |
Lxp Industrial Trust | LXP | Dec 24, 2024 | 8.30 | +0.24 |
LXP Industrial Trust C Pref | LXP-C | Dec 24, 2024 | 48.47 | -0.72 |
Lyell Immunopharma | LYEL | Dec 24, 2024 | 0.61 | -0.44 |
Lyft A | LYFT | Dec 24, 2024 | 13.91 | +1.46 |
LyondellBasell Industries Nv A | LYB | Dec 24, 2024 | 74.12 | +0.15 |
Lyra Therapeutics | LYRA | Dec 24, 2024 | 0.17 | -1.49 |
Lytus Technologies | LYT | Dec 24, 2024 | 0.99 | -16.81 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.